Axiogenesis Cor.At mESC cardiomyocytes

Monday, 21 June, 2010 | Supplied by: Lonza Australia Pty Ltd


Msf249

Embryonic stem cell-derived cardiomyocytes have many of the phenotypic properties of primary cardiomyocytes and show great potential to model human diseases. The Cor.At cells are cardiomyocytes derived from transgenic mouse embryonic stem cells and are available cryopreserved in ampoules.

The cells are highly pure with ampoules containing 99% cardiomyocytes. Their minimal lot-to-lot variation is claimed to give consistent performance and the standardised production process ensures stable supply.

The cardiomyocytes are a good predictive model with relevant background including all important ion channels well characterised.

They are suitable for applications including: electrophysiology (patch clamp, microelectrode arrays, Ca2+ flux analysis), non-arrhythmic cardiotoxicity (cell viability, label-free analysis, troponin release), drug profiling and target discovery (hypertrophy, gene expression, transfection, tissue engineering).

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

BioLamina Laminin-521 cell culture matrix

BioLamina has developed a protocol that eliminates hPSC feeding on Saturdays and Sundays, based...

Agrisera photosynthesis antibodies

Agrisera offers a large collection of validated antibodies. The company has antibodies for a...

GeneTex knockout/knockdown validated antibodies

GeneTex is conducting knockdown-based validation as a fundamental component of its antibody...


  • All content Copyright © 2017 Westwick-Farrow Pty Ltd